Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: a Mendelian Randomization study

BACKGROUND: Fibroblast growth factor 23 (FGF-23) is associated with a range of cardiovascular and non-cardiovascular diseases in conventional epidemiological studies, but substantial residual confounding may exist. Mendelian randomization approaches can help control for such confounding. METHODS: SC...

Descripción completa

Detalles Bibliográficos
Autores principales: Donovan, Killian, Herrington, William G., Paré, Guillaume, Pigeyre, Marie, Haynes, Richard, Sardell, Rebecca, Butterworth, Adam S., Folkersen, Lasse, Gustafsson, Stefan, Wang, Qin, Baigent, Colin, Mälarstig, Anders, Holmes, Michael V., Staplin, Natalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614195/
https://www.ncbi.nlm.nih.gov/pubmed/36719157
http://dx.doi.org/10.2215/CJN.05080422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614195/
https://www.ncbi.nlm.nih.gov/pubmed/36719157
http://dx.doi.org/10.2215/CJN.05080422

Ejemplares similares